Skip to main content
Clinical Trials/ACTRN12623000285651
ACTRN12623000285651
Recruiting
未知

A pilot study designed to compare differences in stimulus evoked electroencephalographic variability between participants assessed to be cognitively normal and participants diagnosed with mild dementia

St Vincent's Hospital Melbourne0 sites48 target enrollmentMarch 16, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Dementia
Sponsor
St Vincent's Hospital Melbourne
Enrollment
48
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 16, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
St Vincent's Hospital Melbourne

Eligibility Criteria

Inclusion Criteria

  • Male and female participants 60 years or older
  • English speaking and basic levels of literacy in order to be able to give informed consent and to follow all instructions
  • Normal or corrected hearing and vision
  • CN group: Formally assessed to be cognitively normal by CADMS Neuropsychiatrist
  • MDAD group: Formal diagnosis by CADMS Neuropsychiatrist of possible or probable Alzheimer's Disease; Mild dementia as defined by Clinical Dementia Rating score of 0\.5 \- 1, Global Deterioration Scale score of 4, and Min\-mental Status Examination score of 18 \- 23

Exclusion Criteria

  • Colour blindness
  • Any history of illness affecting cognitive function e.g., vitamin B12 deficiency, hypothyroidism, significant psychiatric disorders (such as major depression or schizophrenia), neurodegenerative disorders, ischaemic stroke, epilepsy, brain tumour, significant head trauma
  • Any episodes of unexplained loss of consciousness
  • History of substance or alcohol abuse
  • Taking an acetylcholinesterase inhibitor, or any other agent demonstrated to affect cognitive function, within the last 3 months

Outcomes

Primary Outcomes

Not specified

Similar Trials